Mohanad Adel Mohammed

Chromenone-based GSK-3β inhibitors as potential therapeutic targets for cardiovascular diseases: in silico study, molecular dynamics, and ADMET profiles

V. Khori, A. Soltani, Usama S. Altimari, 2022, Arabian Journal of Chemistry.